← Leaderboards
Timothy Yikai Huang
Sanford Burnham Prebys Medical Discovery Institute
$17,668,221
Attributed
$23,016,735
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,016,735 · 9
By mechanism
RF1$12,058,881 · 3
R01$9,885,354 · 4
R21$1,072,500 · 2
Top collaborators
- Randal J. Kaufman4 shared
- Guojun Bu1 shared
- Na Zhao1 shared
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Leon Maing Tai · University Of Illinois At Chicago$5,935,870
Research focus
Alzheimer&AposS Disease RiskPathologicVariantMediatingAmyloid Beta-ProteinPathway InteractionsBrainS DiseaseImpairmentAffectInsightSynapsesMutationMouse ModelFunctional DisorderResponseIn VivoSynaptic FunctionNeuronsNeuroprotectionImpaired CognitionNeurodegenerative DisordersOnset Of Illness
Grant awards (20)
Elucidating a microgliaassociated role for SORLA in modulating AD pathogenesis$867,404
R01 · FY2025 · AG · contact PI
Novel Neuroprotective Roles for the Alzheimer's Disease Risk Gene SORLA in Tau Pathology and Pathogenesis$846,520
R01 · FY2025 · AG · contact PI
Novel Neuroprotective Roles for the Alzheimer's Disease Risk Gene SORLA in Tau Pathology and Pathogenesis$867,695
R01 · FY2024 · AG · contact PI
Molecular pathobiology of soluble TREM2 in Alzheimer's disease$2,655,773
RF1 · FY2023 · AG · contact PI
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"$974,957
R01 · FY2023 · AG
Elucidating a microgliaassociated role for SORLA in modulating AD pathogenesis$2,818,493
RF1 · FY2022 · AG · contact PI
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"$974,758
R01 · FY2022 · AG
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in AD$681,307
R01 · FY2022 · AG · contact PI
Characterizing a potential role for TREM2 in modulating tau pathogenesis in response to Abeta$243,750
R21 · FY2022 · AG · contact PI
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"$971,032
R01 · FY2021 · AG
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in AD$681,080
R01 · FY2021 · AG · contact PI
Characterizing a potential role for TREM2 in modulating tau pathogenesis in response to Abeta$292,500
R21 · FY2021 · AG · contact PI
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"$973,393
R01 · FY2020 · AG
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in AD$682,442
R01 · FY2020 · AG · contact PI
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in AD$682,340
R01 · FY2019 · AG · contact PI
A role for TREM2/Abeta interactions in microglia-regulated AD pathogenesis$243,750
R21 · FY2019 · AG · contact PI
Characterizing neuroprotective roles for SNX27 signaling pathways in AD and DS$2,437,500
RF1 · FY2018 · AG · contact PI
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in AD$682,426
R01 · FY2018 · AG · contact PI
A role for TREM2/Abeta interactions in microglia-regulated AD pathogenesis$292,500
R21 · FY2018 · AG · contact PI
Molecular pathobiology of soluble TREM2 in Alzheimer's disease.$4,147,115
RF1 · FY2017 · AG · contact PI